Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
February 05, 2026
Not intended for U.S. and UK Media – International Stroke Conference (ISC) 2026:
Bayer’s asundexian demonstrated a substantial, 26 percent reduction in stroke after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack with no increase in ISTH major bleeding versus placebo
February 03, 2026
Not intended for U.S. and UK Media
Nubeqa™ (darolutamide) receives third approval in China for men with advanced prostate cancer
January 30, 2026
Not intended for U.S. and UK Media
Finerenone recommended for the treatment of patients with heart failure with LVEF ≥40% in the EU
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
